EP 1231921 A1 20020821 - PROTEASE INHIBITORS
Title (en)
PROTEASE INHIBITORS
Title (de)
PROTEASEINHIBITOREN
Title (fr)
INHIBITEURS DE PROTEASES
Publication
Application
Priority
- US 0030703 W 20001108
- US 16457699 P 19991110
Abstract (en)
[origin: WO0134158A1] This invention relates to the compound of Formula (I), or a pharmaceutically acceptable salt thereof, which is an inhibitor of cysteine proteases, particularly cathepsin K, and is useful in the treatment of diseases in which inhibition of bone loss or of cartilage degradation is a factor.
IPC 1-7
IPC 8 full level
A61K 31/55 (2006.01); A61P 1/02 (2006.01); A61P 19/02 (2006.01); A61P 19/08 (2006.01); A61P 19/10 (2006.01); A61P 21/00 (2006.01); A61P 21/04 (2006.01); A61P 29/00 (2006.01); A61P 33/02 (2006.01); A61P 33/06 (2006.01); A61P 33/08 (2006.01); A61P 35/04 (2006.01); A61P 43/00 (2006.01); C07D 405/14 (2006.01)
CPC (source: EP)
A61K 31/55 (2013.01); A61P 1/02 (2017.12); A61P 19/02 (2017.12); A61P 19/08 (2017.12); A61P 19/10 (2017.12); A61P 21/00 (2017.12); A61P 21/04 (2017.12); A61P 29/00 (2017.12); A61P 33/02 (2017.12); A61P 33/06 (2017.12); A61P 33/08 (2017.12); A61P 35/04 (2017.12); A61P 43/00 (2017.12); C07D 405/14 (2013.01); Y02A 50/30 (2017.12)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0134158 A1 20010517; EP 1231921 A1 20020821; EP 1231921 A4 20040623; JP 2003513926 A 20030415
DOCDB simple family (application)
US 0030703 W 20001108; EP 00977065 A 20001108; JP 2001536156 A 20001108